People · Operator
Named in public records as an officer, director or promoter · active 2010–2023 · Other Health Care, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Phenomix Sciences, Inc. | — | Other Health Care | Series A | $8.6M | $7.1M | 2023 |
| VIA Pharmaceuticals, Inc. | — | Pharmaceuticals | Seed | $4.5M | $121.8M | 2010 |
Lawrence K Cohen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Lawrence K Cohen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James G Stewart | 1 | 3 |
| Fred B. Craves | 1 | 3 |
| Mark Bagnall | 1 | 3 |
| LAWRENCE COHEN | 1 | 3 |
| Karl Ronn | 1 | 2 |
| Andres Acosta | 1 | 2 |
| Michael Camilleri | 1 | 2 |
| Karen S. Wright | 1 | 2 |
| Rebecca A. Taub | 1 | 2 |
| Mark Bengall | 1 | 1 |
| Douglass B Given | 1 | 1 |
| Mark NK Bagnall | 1 | 1 |
| David T Howard | 1 | 1 |
| Karl K Ronn | 1 | 1 |
| John R Larson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.